Interstitial Cystitis / Painful Bladder Syndrome: Epidemiology

The summary for the Interstitial Cystitis / Painful Bladder Syndrome: Epidemiology grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Interstitial Cystitis / Painful Bladder Syndrome: Epidemiology: The Division of Kidney, Urologic and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Office of Research on Womens Health (ORWH) invites cooperative agreement applications for investigation of the epidemiology of interstitial cystitis and painful bladder syndrome (IC/PBS). The purpose of this solicitation will be to establish a study group that will develop and conduct epidemiologic investigations using a population based sampling strategy to identify and characterize patients with symptoms consistent with interstitial cystitis or painful bladder syndrome. The studies will characterize the patients clinically and demographically, establish risk factors, duration of symptoms, current methods of treatment and describe the economic burden of disease. The study protocol(s) must include the provision for an intensive clinical evaluation of a subset of the symptomatic subjects and matched controls, utilizing clinicians experienced in the diagnosis of interstitial cystitis.

Federal Grant Title:	Interstitial Cystitis / Painful Bladder Syndrome: Epidemiology
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-04-009
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.849
CFDA Descriptions:	Kidney Diseases, Urology and Hematology Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Mar 22, 2004
Posted Date:	Jan 23, 2004
Creation Date:	Apr 21, 2004
Archive Date:	Apr 21, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Investigations on Primary Immunodeficiency Diseases (R01); • Grants for Basic Research in Glomerular Diseases (R01); • Advances in Polycystic Kidney Disease (R01); • Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...; • Calcium Oxalate Stone Diseases (R01); • Research Grants for Clinical Studies of Kidney Diseases; • Chronic Prostatitis Collaborative Research Network (Cpcrn); • Frequent Hemodialysis Clinical Trials
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...